179 related articles for article (PubMed ID: 34433451)
1. Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments.
Zhao J; Hu Y; Zhao Y; Chen D; Fang T; Ding M
BMC Womens Health; 2021 Aug; 21(1):312. PubMed ID: 34433451
[TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
[TBL] [Abstract][Full Text] [Related]
3. Identifying women 45 years and younger at elevated risk for endometrial hyperplasia or cancer.
Beavis AL; Blechter B; Najjar O; Fader AN; Katebi Kashi P; Rositch AF
Gynecol Oncol; 2023 Jul; 174():98-105. PubMed ID: 37172411
[TBL] [Abstract][Full Text] [Related]
4. Concurrent endometrial carcinoma in hysterectomy specimens in patients with histopathological diagnosis of endometrial hyperplasia in curettage specimens.
Dolanbay M; Kutuk MS; Uludag S; Bulut AN; Ozgun MT; Ozcelik B; Serin IS
Ginekol Pol; 2015 Oct; 86(10):753-8. PubMed ID: 26677585
[TBL] [Abstract][Full Text] [Related]
5. Association of endometrial hyperplasia and cancer with a history of gestational diabetes.
Wartko PD; Beck TL; Reed SD; Mueller BA; Hawes SE
Cancer Causes Control; 2017 Aug; 28(8):819-828. PubMed ID: 28577154
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of endometrial hyperplasia: A UK national audit of adherence to national guidance 2012-2020.
Henderson I; Black N; Khattak H; ; Gupta JK; Rimmer MP
PLoS Med; 2024 Feb; 21(2):e1004346. PubMed ID: 38421942
[TBL] [Abstract][Full Text] [Related]
7. Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan.
Lacey JV; Chia VM; Rush BB; Carreon DJ; Richesson DA; Ioffe OB; Ronnett BM; Chatterjee N; Langholz B; Sherman ME; Glass AG
Int J Cancer; 2012 Oct; 131(8):1921-9. PubMed ID: 22290745
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study.
Jeong JY; Hwang SO; Lee B; Kim K; Kim YB; Park SH; Choi HY
PLoS One; 2020; 15(12):e0243064. PubMed ID: 33259545
[TBL] [Abstract][Full Text] [Related]
9. Management and clinical outcomes of endometrial hyperplasia during a 13-year period in Songklanagarind Hospital.
Sirimusika N; Peeyananjarassri K; Suphasynth Y; Wootipoom V; Kanjanapradit K; Geater A
J Med Assoc Thai; 2014 Mar; 97(3):260-6. PubMed ID: 25123004
[TBL] [Abstract][Full Text] [Related]
10. Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia.
Bilgin T; Ozuysal S; Ozan H; Atakan T
J Obstet Gynaecol Res; 2004 Jun; 30(3):205-9. PubMed ID: 15210044
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
Morelli M; Di Cello A; Venturella R; Mocciaro R; D'Alessandro P; Zullo F
Gynecol Endocrinol; 2013 Feb; 29(2):156-9. PubMed ID: 23134558
[TBL] [Abstract][Full Text] [Related]
12. Prediction of endometrial carcinogenesis probability while diagnosed as atypical endometrial hyperplasia: a new risk model based on age, CA199 and CA125 assay.
Zhou L; Meng Z; Wu Y; Zhu H; Wang X
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():5-9. PubMed ID: 25461342
[TBL] [Abstract][Full Text] [Related]
13. Nodal Assessment in Endometrial Atypical Hyperplasia.
Capozzi VA; Sozzi G; Butera D; Chiantera V; Ghi T; Berretta R
Gynecol Obstet Invest; 2022; 87(3-4):226-231. PubMed ID: 35793641
[TBL] [Abstract][Full Text] [Related]
14. Risk of More Advanced Lesions at Hysterectomy after Initial Diagnosis of Non-Atypical Endometrial Hyperplasia in Patients with Postmenopausal Bleeding and Oral Anticoagulant Treatment.
Carabineanu A; Zaharia C; Blidisel A; Ilina R; Miclaus C; Ardelean O; Preda M; Mazilu O
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684040
[No Abstract] [Full Text] [Related]
15. Endometrial cancer patients understanding and interest in weight loss surgery.
Wiley RL; Urbauer DL; Nugent E; Gallegos J; Ramondetta L
Gynecol Oncol; 2023 Aug; 175():88-92. PubMed ID: 37329873
[TBL] [Abstract][Full Text] [Related]
16. Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia.
Suidan RS; He W; Sun CC; Zhao H; Fleming ND; Ramirez PT; Soliman PT; Westin SN; Lu KH; Giordano SH; Meyer LA
Gynecol Oncol; 2017 Apr; 145(1):55-60. PubMed ID: 28131529
[TBL] [Abstract][Full Text] [Related]
17. PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Viggiani M; Giampaolino P; Insabato L; Mollo A; De Placido G; Zullo F
Arch Gynecol Obstet; 2019 Jun; 299(6):1511-1524. PubMed ID: 30915635
[TBL] [Abstract][Full Text] [Related]
18. Endometrial hyperplasia in infertile women undergoing IVF/ICSI: A retrospective cross-sectional study.
Tian Y; Liu Y; Wang G; Lv Y; Zhang J; Bai X; Zhang H; Song X
J Gynecol Obstet Hum Reprod; 2020 Nov; 49(9):101780. PubMed ID: 32360632
[TBL] [Abstract][Full Text] [Related]
19. Contrast enhanced ultrasound in diagnosis of endometrial carcinoma and endometrial hyperplasia.
Su Q; Sun Z; Lv G
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):88-91. PubMed ID: 30213295
[TBL] [Abstract][Full Text] [Related]
20. Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia.
Matsuo K; Ramzan AA; Gualtieri MR; Mhawech-Fauceglia P; Machida H; Moeini A; Dancz CE; Ueda Y; Roman LD
Gynecol Oncol; 2015 Nov; 139(2):261-7. PubMed ID: 26238457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
